CNMD formed double bottomCONMED CorporationBATS:CNMDstocktwistsCNMD formed double bottom and nice breakout from trend line in daily chart expecting good move from here Consensus Rating CONMED has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 6 hold ratings, and 1 sell rating. Upside Potential CONMED has a consensus price target of $52.83, representing about 16.9% upside from its current price of $45.18. Amount of Analyst Coverage CONMED has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. fundamentals:- With a presence in over 70 countries, CONMED sells products through direct sales forces as well as distributor partnerships. The company’s international footprint spans North America, Europe, Latin America, Asia Pacific and select emerging markets. CONMED works closely with healthcare facilities and surgical centers to deliver training, technical support and service solutions tailored to local regulatory requirements and clinical practices. Leadership at CONMED includes President and Chief Executive Officer Jeffrey M. Dunn, whose tenure has focused on strategic growth through product innovation and targeted acquisitions. Over its history, the company has expanded both organically and via the integration of complementary businesses to broaden its capabilities in key procedural areas. CONMED remains committed to advancing minimally invasive surgical technologies and supporting clinicians worldwide.